1. L-Carnitine in the Secondary Prevention of Cardiovascular Disease: Systematic Review and Meta-analysis 
James J. DiNicolantonio, PharmD, Carl J. Lavie, MD, Hassan Fares, MD, Arthur R. Menezes, MD, James H. O'Keefe, MD 
Mayo Clinic Proceedings 
Volume 88, Issue 6, Pages (June 2013)
DOI: /j.mayocp
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

2. Figure 1 Process for selecting included trials.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

3. Figure 2
Forest plot of odds ratios for all-cause mortality. IV = inverse variance.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

4. Figure 3
Forest plot of risk ratios for ventricular arrhythmia. IV = inverse variance.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

5. Figure 4
Forest plot of risk ratios for myocardial reinfarction. IV = inverse variance.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

6. Figure 5
Forest plot of risk ratios for the development of HF. IV = inverse variance.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

7. Figure 6
Forest plot of risk ratios for the development of angina. IV = inverse variance.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions

8. Figure 7
Forest plot of risk ratios for all-cause mortality including and excluding small studies. IV = inverse variance.
Mayo Clinic Proceedings  , DOI: ( /j.mayocp )
Copyright © 2013 Mayo Foundation for Medical Education and Research Terms and Conditions